Literature DB >> 20512993

A flippase-independent function of ATP8B1, the protein affected in familial intrahepatic cholestasis type 1, is required for apical protein expression and microvillus formation in polarized epithelial cells.

Patricia M Verhulst1, Lieke M van der Velden, Viola Oorschot, Ernst E van Faassen, Judith Klumperman, Roderick H J Houwen, Thomas G Pomorski, Joost C M Holthuis, Leo W J Klomp.   

Abstract

UNLABELLED: Mutations in ATP8B1 cause familial intrahepatic cholestasis type 1, a spectrum of disorders characterized by intrahepatic cholestasis, reduced growth, deafness, and diarrhea. ATP8B1 belongs to the P(4) P-type adenosine triphosphatase (ATPase) family of putative aminophospholipid translocases, and loss of aminophospholipid asymmetry in the canalicular membranes of ATP8B1-deficient liver cells has been proposed as the primary cause of impaired bile salt excretion. To explore the origin of the hepatic and extrahepatic symptoms associated with ATP8B1 deficiency, we investigated the impact of ATP8B1 depletion on the domain-specific aminophospholipid translocase activities and polarized organization of polarized epithelial Caco-2 cells. Caco-2 cells were stably transfected with short hairpin RNA constructs to block ATP8B1 expression. Aminophospholipid translocase activity was assessed using spin-labeled phospholipids. The polarized organization of these cells was determined by pulse-chase analysis, cell-fractionation, immunocytochemistry, and transmission electron microscopy. ATP8B1 was abundantly expressed in the apical membrane of Caco-2 cells, and its expression was markedly induced during differentiation and polarization. Blocking ATP8B1 expression by RNA interference (RNAi) affected neither aminophospholipid transport nor the asymmetrical distribution of aminophospholipids across the apical bilayer. Nonetheless, ATP8B1-depleted Caco-2 cells displayed profound perturbations in apical membrane organization, including a disorganized apical actin cytoskeleton, a loss in microvilli, and a posttranscriptional defect in apical protein expression.
CONCLUSION: Our findings point to a critical role of ATP8B1 in apical membrane organization that is unrelated to its presumed aminophospholipid translocase activity, yet potentially relevant for the development of cholestasis and the manifestation of extrahepatic features associated with ATP8B1 deficiency.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20512993     DOI: 10.1002/hep.23586

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  25 in total

1.  Heteromeric interactions required for abundance and subcellular localization of human CDC50 proteins and class 1 P4-ATPases.

Authors:  Lieke M van der Velden; Catharina G K Wichers; Adriana E D van Breevoort; Jonathan A Coleman; Robert S Molday; Ruud Berger; Leo W J Klomp; Stan F J van de Graaf
Journal:  J Biol Chem       Date:  2010-10-14       Impact factor: 5.157

2.  Directed evolution of a sphingomyelin flippase reveals mechanism of substrate backbone discrimination by a P4-ATPase.

Authors:  Bartholomew P Roland; Todd R Graham
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-18       Impact factor: 11.205

3.  Circulating platelet-activating factor is primarily cleared by transport, not intravascular hydrolysis by lipoprotein-associated phospholipase A2/ PAF acetylhydrolase.

Authors:  Jinbo Liu; Rui Chen; Gopal K Marathe; Maria Febbraio; Weilin Zou; Thomas M McIntyre
Journal:  Circ Res       Date:  2010-12-23       Impact factor: 17.367

4.  Human TMEM30a promotes uptake of antitumor and bioactive choline phospholipids into mammalian cells.

Authors:  Rui Chen; Erin Brady; Thomas M McIntyre
Journal:  J Immunol       Date:  2011-02-02       Impact factor: 5.422

5.  The flip side of cardiolipin import.

Authors:  Coen C Paulusma; Roderick H J Houwen; Patrick L Williamson
Journal:  Nat Med       Date:  2011-04       Impact factor: 53.440

Review 6.  Progressive familial intrahepatic cholestasis.

Authors:  Anshu Srivastava
Journal:  J Clin Exp Hepatol       Date:  2013-11-23

7.  Biochemical characterization of P4-ATPase mutations identified in patients with progressive familial intrahepatic cholestasis.

Authors:  Alex Stone; Christopher Chau; Christian Eaton; Emily Foran; Mridu Kapur; Edward Prevatt; Nathan Belkin; David Kerr; Torvald Kohlin; Patrick Williamson
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

8.  Phospholipid flippase activities and substrate specificities of human type IV P-type ATPases localized to the plasma membrane.

Authors:  Hiroyuki Takatsu; Gaku Tanaka; Katsumori Segawa; Jun Suzuki; Shigekazu Nagata; Kazuhisa Nakayama; Hye-Won Shin
Journal:  J Biol Chem       Date:  2014-10-14       Impact factor: 5.157

9.  New paradigms of USP53 disease: normal GGT cholestasis, BRIC, cholangiopathy, and responsiveness to rifampicin.

Authors:  Hamoud Alhebbi; Abdul Ali Peer-Zada; Abdulrahman A Al-Hussaini; Sara Algubaisi; Awad Albassami; Nasser AlMasri; Yasir Alrusayni; Ibrahim M Alruzug; Essa Alharby; Manar A Samman; Syed Zubair Ayoub; Sateesh Maddirevula; Roy W A Peake; Fowzan S Alkuraya; Sami Wali; Naif A M Almontashiri
Journal:  J Hum Genet       Date:  2020-08-06       Impact factor: 3.172

10.  Phospholipase D2 mediates signaling by ATPase class I type 8B membrane 1.

Authors:  Frank Chen; Ayantika Ghosh; Benjamin L Shneider
Journal:  J Lipid Res       Date:  2012-12-04       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.